← The Wire
EDSANasdaq
Edesa Biotech, Inc.
Pharmaceutical Preparations · A1 · CIK 1540159
Edesa Biotech develops innovative drug candidates for inflammatory and immune-related diseases, focusing on dermatology and respiratory conditions
red 8-K · 90d
$52M
Market cap
$7.67
Last close
-6.3%
1D
+12.6%
5D
75K
Volume
Price · last 39 sessions-52.4%
May 4L $4.94 · H $17.43Jun 29
341
Total filings
Jun 11, 2026
Last filing
09/30
Fiscal year end
DEF 14AFORM DEF 14AApr 3, 2026DEF 14ADEFINITIVE PROXY STATEMENTApr 4, 2025DEF 14ADEF 14AApr 5, 2024DEF 14AFORM DEF 14AMar 28, 2023DEF 14ASCHEDULE-14AApr 1, 2022DEF 14ADEF 14AMar 3, 2021DEF 14ADEF 14AMar 23, 2020DEF 14ADEF 14AFeb 13, 2018DEF 14ADEF 14AFeb 1, 2017DEF 14ADEFINITIVE PROXY STATEMENTJan 25, 2016DEF 14ADEF 14ASep 28, 2015DEF 14AFORM DEF 14AJan 13, 2015
Insider Activity
◆ Cluster Buy · 2 insidersIn the 90 days to Mar 10, 2026: 2 insiders bought $233K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 10, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 1,000 | $6.60 | $7K |
| Mar 5, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 10,000 | $3.90 | $39K |
| Mar 4, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 10,000 | $4.26 | $43K |
| Mar 3, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 10,000 | $3.63 | $36K |
| Mar 2, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 2,000 | $2.00 | $4K |
| Mar 2, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 1,000 | $2.28 | $2K |
| Feb 27, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 30,000 | $2.22 | $67K |
| Feb 26, 2026 | Nijhawan PardeepChief Executive Officer | Buy | 20,571 | $1.58 | $33K |
| Feb 26, 2026 | Brooks Michael JPresident | Buy | 2,000 | $1.57 | $3K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance